Aquarius Surgical Technologies Inc.
ASTI
CNSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -77.18% | -40.22% | -54.45% | -5.49% | 43.55% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -77.18% | -40.22% | -54.45% | -5.49% | 43.55% |
| Cost of Revenue | -74.35% | 145.28% | -45.71% | -29.94% | -19.07% |
| Gross Profit | -79.64% | -64.37% | -61.47% | 33.02% | 333.33% |
| SG&A Expenses | 45.25% | -23.17% | 11.24% | -8.52% | -39.64% |
| Depreciation & Amortization | -8.77% | -8.47% | 1.79% | 46.15% | 850.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.79% | -16.72% | 2.43% | -9.53% | -33.79% |
| Operating Income | -78.30% | 6.52% | -30.41% | 10.40% | 49.04% |
| Income Before Tax | -27.98% | -29.38% | -18.18% | -106.15% | 28.64% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -27.98% | -29.38% | -16.98% | -112.96% | 28.64% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -27.98% | -29.38% | -16.98% | -112.96% | 28.64% |
| EBIT | -78.30% | 6.52% | -30.41% | 10.40% | 49.04% |
| EBITDA | -85.55% | 6.40% | -30.39% | 10.63% | 52.76% |
| EPS Basic | -28.57% | -31.11% | -18.00% | -110.71% | 37.18% |
| Normalized Basic EPS | -43.33% | -24.14% | -23.33% | 0.00% | 37.50% |
| EPS Diluted | -28.57% | -31.11% | -18.00% | -110.71% | 37.18% |
| Normalized Diluted EPS | -43.33% | -24.14% | -23.33% | 0.00% | 37.50% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.18% | 12.70% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.18% | 12.70% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
